Engrail Therapeutics INC
8 clinical trials · Sponsor
◉ Watch Engrail Therapeutics INC
| Record | Firm | Date |
|---|---|---|
| A Study of ENX-104 in Healthy Participants (NCT07472361) | Engrail Therapeutics INC | 2026-02-25 |
| A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder (NCT07193563) | Engrail Therapeutics INC | 2025-09-05 |
| ENX-205 SAD/PET Study in Healthy Adults (NCT07253246) | Engrail Therapeutics INC | 2025-03-23 |
| A PET Study of ENX-104 in Healthy Volunteers (NCT07253272) | Engrail Therapeutics INC | 2025-02-24 |
| ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD) (NCT07253324) | Engrail Therapeutics INC | 2025-02-17 |
| A Dose-Response Safety Study of ENX-102 in Patients With GAD (NCT06653296) | Engrail Therapeutics INC | 2024-12-09 |
| ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder (NCT05749055) | Engrail Therapeutics INC | 2023-07-03 |
| ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures (NCT05481905) | Engrail Therapeutics INC | 2022-09-01 |
Track Engrail Therapeutics INC automatically
Every clearance here is in the API, with alerts when new ones post.